Literature DB >> 23280841

Substantia nigra depigmentation and exposure to encephalitis lethargica.

Nawaz Hack1, Gregory A Jicha, Annalisa Abell, Dawson Dean, Jerrold L Vitek, Joseph R Berger.   

Abstract

OBJECTIVE: Parkinsonism has occasionally been reported as a consequence of infectious diseases. The present study examines the clinical and pathological correlates of parkinsonism across birth cohorts in relation to critical exposure to the encephalitis lethargica epidemic in the early 1900s.
METHODS: The study population consisted of 678 participants in the Nun Study, of whom 432 died and came to autopsy. Qualitative indices of substantia nigra (SN) depigmentation were verified in a subset of 40 randomly selected subjects using quantitative stereological techniques. SN depigmentation, detected neuropathologically, was correlated with clinical parameters of Parkinson disease, age, and birth cohort.
RESULTS: SN depigmentation was detected in 57 (13.2%) of the cohort. Although qualitative SN depigmentation correlated modestly with age (p = 0.02), it correlated best with birth cohort (p = 0.009) for women born in the years 1895-1899. Quantitative measures of SN depigmentation were increased in this birth cohort compared to age matched subjects from flanking birth cohorts 1890-1894 and 1900-1904 (p < 0.001). SN depigmentation correlated with speed of 6- and 50-foot walk (p < 0.0001), up and go test (p < 0.0001), and hand coordination (p < 0.0001).
INTERPRETATION: Subjects in the birth cohort 1895-1899 would have been in their late teens and 20s at the onset and during the peak of the encephalitis lethargica epidemic. These were precisely the age ranges of persons who were most often affected by the illness. These data suggest the possibility that the coexistence of parkinsonism and SN depigmentation in this birth cohort may have resulted from the yet undetermined infectious agent responsible for encephalitis lethargica.
Copyright © 2012 American Neurological Association.

Entities:  

Mesh:

Year:  2012        PMID: 23280841      PMCID: PMC3660013          DOI: 10.1002/ana.23697

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

Review 1.  Etiology of Parkinson's disease.

Authors:  A J Stoessl
Journal:  Can J Neurol Sci       Date:  1999-08       Impact factor: 2.104

2.  Acute reversible parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness.

Authors:  Petia S Dimova; Veneta Bojinova; Dimitar Georgiev; Ivan Milanov
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

3.  Studies in the epidemiology of Parkinson's disease predicting its disappearance as a major clinical entity by 1980.

Authors:  D C POSKANZER; R S SCHWAB
Journal:  Trans Am Neurol Assoc       Date:  1961

4.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

5.  Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.

Authors:  S Morris; M E Morris; R Iansek
Journal:  Phys Ther       Date:  2001-02

6.  Movement disorders in 28 HIV-infected patients.

Authors:  James Pitágoras de Mattos; Ana Lúcia Zuma de Rosso; Rosalie Branco Correa; Sérgio A P Novis
Journal:  Arq Neuropsiquiatr       Date:  2002-09       Impact factor: 1.420

7.  A fatal case of coxsackievirus B4 meningoencephalitis.

Authors:  Bruce C Cree; Gary L Bernardini; Arthur P Hays; Gina Lowe
Journal:  Arch Neurol       Date:  2003-01

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 9.  Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.

Authors:  Paul M Carvey; Qin Chang; Jack W Lipton; Zaodung Ling
Journal:  Front Biosci       Date:  2003-09-01

10.  Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Tsuyoshi Furuya; Hideki Hayakawa; Masanori Yamada; Kenji Yoshimi; Shin Hisahara; Masayuki Miura; Yoshikuni Mizuno; Hideki Mochizuki
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

View more
  5 in total

1.  An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Authors:  Grant Coan; Cassie S Mitchell
Journal:  Neurodegener Dis       Date:  2015-07-16       Impact factor: 2.977

Review 2.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

3.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

4.  The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.

Authors:  Danny Estupinan; Sunina Nathoo; Michael S Okun
Journal:  Parkinsons Dis       Date:  2013-06-11

5.  An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.

Authors:  Nawaz Hack; Sarah M Fayad; Erin H Monari; Umer Akbar; Angela Hardwick; Ramon L Rodriguez; Irene A Malaty; Janet Romrell; Aparna A Wagle Shukla; Nikolaus McFarland; Herbert E Ward; Michael S Okun
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.